Literature DB >> 26687139

Study of the Annexin A1 and Its Associations with Carcinoembryonic Antigen and Mismatch Repair Proteins in Colorectal Cancer.

Lenuce Ribeiro Aziz Ydy1, Gilmar Ferreira do Espírito Santo2, Ivana de Menezes3,4, Michelle Santos Martins5, Eliane Ignotti3,6, Amílcar Sabino Damazo7,8.   

Abstract

PURPOSE: Annexin-A1 (ANXA1) has been implicated in various tumor types, but few studies have investigated its involvement in colorectal cancer. The study aimed to analyze ANXA1 expression in the normal margin and colorectal tumor tissues of 104 patients who underwent surgery for colorectal cancer and to associate the ANXA1 expression with predictive clinicopathological variables.
METHODS: Hematoxylin-eosin and immunohistochemical staining were used for the analysis.
RESULTS: ANXA1 expression was higher in colorectal cancer than in normal margin tissue (p = 0.0001). However, no differences were observed when we analyzed the ANXA1 expression in colon and rectal tumors (p = 0.830). Also, this protein positivity was associated with increased carcinoembryonic antigen levels (p = 0.004). Our data in the DNA-mismatch repair proteins expression was in accordance to the literature. And their positivity was not associated with ANXA1 presence in colorectal cancer.
CONCLUSION: The high incidence of ANXA1 positive expression in colorectal cancer and its association with carcinoembryonic antigen levels might indicate the importance of this protein in the colorectal cancer biology.

Entities:  

Keywords:  Annexin A1; Carcinoembryonic antigen levels; Colorectal tumor; Mismatch repair proteins

Mesh:

Substances:

Year:  2016        PMID: 26687139     DOI: 10.1007/s12029-015-9791-3

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  24 in total

1.  Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface.

Authors:  E Solito; H C Christian; M Festa; A Mulla; T Tierney; R J Flower; J C Buckingham
Journal:  FASEB J       Date:  2006-05-23       Impact factor: 5.191

Review 2.  Prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer.

Authors:  J M Church
Journal:  Ann Med       Date:  1996-12       Impact factor: 4.709

3.  Human annexin 1 is highly expressed during the differentiation of the epithelial cell line A 549: involvement of nuclear factor interleukin 6 in phorbol ester induction of annexin 1.

Authors:  E Solito; C de Coupade; L Parente; R J Flower; F Russo-Marie
Journal:  Cell Growth Differ       Date:  1998-04

4.  Up-regulated Annexin A1 expression in gastrointestinal cancer is associated with cancer invasion and lymph node metastasis.

Authors:  Yu Sato; Kensuke Kumamoto; Katsuharu Saito; Hirokazu Okayama; Suguru Hayase; Yasuhide Kofunato; Koutaro Miyamoto; Izumi Nakamura; Shinji Ohki; Yoshihisa Koyama; Seiichi Takenoshita
Journal:  Exp Ther Med       Date:  2011-01-20       Impact factor: 2.447

5.  p53 mutation is common in microsatellite stable, BRAF mutant colorectal cancers.

Authors:  Catherine E Bond; Aarti Umapathy; Ingunn Ramsnes; Sonia A Greco; Zhen Zhen Zhao; Kylie-Ann Mallitt; Ron L Buttenshaw; Grant W Montgomery; Barbara A Leggett; Vicki L J Whitehall
Journal:  Int J Cancer       Date:  2011-08-03       Impact factor: 7.396

6.  Comparison of microsatellite instability and chromosomal instability in predicting survival of patients with T3N0 colorectal cancer.

Authors:  Pascal Gervaz; Jean-Philippe Cerottini; Hanifa Bouzourene; Dieter Hahnloser; Christy L Doan; Jean Benhattar; Pascal Chaubert; Michelle Secic; Michel Gillet; John M Carethers
Journal:  Surgery       Date:  2002-02       Impact factor: 3.982

7.  Immunostaining of colorectal cancer with monoclonal anti-CEA antibodies compared to serum and tumor CEA content.

Authors:  M Pagé; I Dalifard; G Bertrand; P G Bocquillon; A Daver
Journal:  Anticancer Res       Date:  1986 Sep-Oct       Impact factor: 2.480

8.  Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients.

Authors:  I Tarantino; R Warschkow; M Worni; K Merati-Kashani; D Köberle; B M Schmied; S A Müller; T Steffen; T Cerny; U Güller
Journal:  Br J Cancer       Date:  2012-06-26       Impact factor: 7.640

9.  Characterisation and protein expression profiling of annexins in colorectal cancer.

Authors:  R Duncan; B Carpenter; L C Main; C Telfer; G I Murray
Journal:  Br J Cancer       Date:  2007-12-11       Impact factor: 7.640

10.  Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma.

Authors:  Thaís Santana Gastardelo; Bianca Rodrigues Cunha; Luís Sérgio Raposo; José Victor Maniglia; Patrícia Maluf Cury; Flávia Cristina Rodrigues Lisoni; Eloiza Helena Tajara; Sonia Maria Oliani
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

View more
  4 in total

1.  MicroRNA-26a regulates ANXA1, rather than DAL-1, in the development of lung cancer.

Authors:  Tonghui Cai; Xiaoying Guan; Hongyan Wang; Ying Fang; Jie Long; Xiaobin Xie; Yajie Zhang
Journal:  Oncol Lett       Date:  2018-02-14       Impact factor: 2.967

2.  Annexin A13 promotes tumor cell invasion in vitro and is associated with metastasis in human colorectal cancer.

Authors:  Guozhong Jiang; Pengju Wang; Weiwei Wang; Wencai Li; Liping Dai; Kuisheng Chen
Journal:  Oncotarget       Date:  2017-03-28

3.  Expression levels and prognostic values of annexins in liver cancer.

Authors:  Chunbo Zhuang; Pei Wang; Ting Sun; Lei Zheng; Liang Ming
Journal:  Oncol Lett       Date:  2019-10-30       Impact factor: 2.967

4.  Proteomics analysis of the matrisome from MC38 experimental mouse liver metastases.

Authors:  Arseniy E Yuzhalin; Su Yin Lim; Alex N Gordon-Weeks; Roman Fischer; Benedikt M Kessler; Dihua Yu; Ruth J Muschel
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-09-23       Impact factor: 4.052

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.